|
Name |
Acaciicolinol G
|
| Molecular Formula | C15H26O3 | |
| IUPAC Name* |
(1R,2R,3R,6R)-9-(hydroxymethyl)-1,5,5-trimethylspiro[5.5]undec-9-ene-2,3-diol
|
|
| SMILES |
C[C@H]1[C@H]([C@@H](CC([C@@]12CCC(=CC2)CO)(C)C)O)O
|
|
| InChI |
InChI=1S/C15H26O3/c1-10-13(18)12(17)8-14(2,3)15(10)6-4-11(9-16)5-7-15/h4,10,12-13,16-18H,5-9H2,1-3H3/t10-,12+,13+,15-/m0/s1
|
|
| InChIKey |
CZGPFTWSQIUAET-ZGFBFQLVSA-N
|
|
| Synonyms |
Acaciicolinol G
|
|
| CAS | NA | |
| PubChem CID | 139590766 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 254.36 | ALogp: | 1.6 |
| HBD: | 3 | HBA: | 3 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 60.7 | Aromatic Rings: | 2 |
| Heavy Atoms: | 18 | QED Weighted: | 0.63 |
| Caco-2 Permeability: | -4.697 | MDCK Permeability: | 0.00001050 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.028 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.963 |
| 30% Bioavailability (F30%): | 0.096 |
| Blood-Brain-Barrier Penetration (BBB): | 0.195 | Plasma Protein Binding (PPB): | 86.01% |
| Volume Distribution (VD): | 1.11 | Fu: | 20.16% |
| CYP1A2-inhibitor: | 0.037 | CYP1A2-substrate: | 0.166 |
| CYP2C19-inhibitor: | 0.016 | CYP2C19-substrate: | 0.766 |
| CYP2C9-inhibitor: | 0.015 | CYP2C9-substrate: | 0.624 |
| CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.315 |
| CYP3A4-inhibitor: | 0.048 | CYP3A4-substrate: | 0.108 |
| Clearance (CL): | 4.166 | Half-life (T1/2): | 0.752 |
| hERG Blockers: | 0.059 | Human Hepatotoxicity (H-HT): | 0.054 |
| Drug-inuced Liver Injury (DILI): | 0.063 | AMES Toxicity: | 0.012 |
| Rat Oral Acute Toxicity: | 0.04 | Maximum Recommended Daily Dose: | 0.023 |
| Skin Sensitization: | 0.678 | Carcinogencity: | 0.054 |
| Eye Corrosion: | 0.01 | Eye Irritation: | 0.855 |
| Respiratory Toxicity: | 0.501 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003905 | ![]() |
0.574 | D08PIQ | ![]() |
0.274 | ||
| ENC003909 | ![]() |
0.548 | D0KR5B | ![]() |
0.266 | ||
| ENC003903 | ![]() |
0.477 | D0D1SG | ![]() |
0.266 | ||
| ENC003913 | ![]() |
0.463 | D07DVK | ![]() |
0.255 | ||
| ENC003907 | ![]() |
0.455 | D0CW1P | ![]() |
0.255 | ||
| ENC003908 | ![]() |
0.455 | D0IT2G | ![]() |
0.255 | ||
| ENC005118 | ![]() |
0.433 | D0CZ1Q | ![]() |
0.247 | ||
| ENC003912 | ![]() |
0.412 | D0R7JT | ![]() |
0.247 | ||
| ENC003911 | ![]() |
0.412 | D0V9DZ | ![]() |
0.247 | ||
| ENC003897 | ![]() |
0.377 | D04VIS | ![]() |
0.247 | ||